March 25, 2021 — U.S. imports expert and FDAimports.com Founder and CEO Benjamin England said the U.S. Food and Drug Administration (FDA) may try new tactics related to records and documentation in place of actual inspections in order to regulate the seafood industry.
Speaking at a panel during Seafood Expo North America Reconnect, England said he’s seen increased activity from the FDA on records requests. Key to that, he said, is the FDA’s attempts to continue to conduct inspection activity during the COVID-19 pandemic.